YLZ(SZ:300096)2021-04-28 16:00Financial Performance - The company's operating revenue for 2020 was ¥1,051,064,058.34, representing a 10.79% increase compared to ¥948,718,436.87 in 2019[17]. - The net profit attributable to shareholders for 2020 was ¥11,476,313.15, a 9.24% increase from ¥10,505,744.63 in the previous year[17]. - The basic earnings per share for 2020 was ¥0.027, up 12.50% from ¥0.024 in 2019[17]. - The company reported a quarterly revenue of ¥429,026,675.32 in Q4 2020, marking a significant increase from previous quarters[20]. - The company experienced a net profit of ¥51,657,574.41 in Q4 2020, a recovery from losses in earlier quarters[20]. - The revenue from the livelihood service sector was ¥924,156,509.52, accounting for 87.93% of total revenue, with a year-on-year growth of 2.98%[62]. - The financing service revenue decreased significantly by 84.27%, dropping to ¥6,676,531.28 from ¥42,456,973.94[62]. - The insurance brokerage sector saw a remarkable increase of 1,354.23%, with revenue rising to ¥119,554,303.24 from ¥8,221,167.29[62]. - The company reported a gross margin of 52.54% in the民生服务行业, with a slight increase of 0.01% compared to the previous year[65]. - The total operating costs for 2020 were 1,020,000,000 CNY, with a significant increase in costs related to technical services and data services, which rose by 1,642.91%[68]. Cash Flow and Investments - The net cash flow from operating activities was negative at -¥58,728,017.29, a significant decline of 192.49% compared to ¥63,494,197.92 in 2019[17]. - Operating cash inflow totaled CNY 1.16 billion in 2020, a 6.61% increase from CNY 1.08 billion in 2019, while cash outflow rose by 19.00% to CNY 1.21 billion[82]. - The net cash flow from investment activities decreased by 53.11%, mainly due to a significant cash recovery from investments in the previous year[84]. - The net cash flow from financing activities increased by 102.14%, primarily due to increased cash received from minority shareholders' investments in subsidiaries[84]. - The total investment during the reporting period was 67,085,000.00, an increase of 17.85% compared to the previous year's investment of 56,925,007.09[92]. - The company reported an investment loss of -15,576,085.45, accounting for -28.92% of total profit[86]. Dividend Distribution - The company plans to distribute a cash dividend of 0.05 yuan per 10 shares to all shareholders, based on a total of 430,000,000 shares[4]. - The total cash dividend distributed for 2020 was 2,150,000 yuan, representing 18.73% of the net profit attributable to shareholders[128]. - The cash dividend per 10 shares was set at 0.05 yuan (including tax) for the year 2020, consistent with the previous two years[127]. - The cash dividend accounted for 100% of the total profit distribution for the year 2020[125]. - The company has maintained a consistent cash dividend policy over the past three years, with the same amount distributed each year[128]. Operational Strategy and Innovation - The company emphasizes the importance of risk awareness regarding future plans and performance forecasts, highlighting potential risks and countermeasures in its operational outlook[4]. - The company is committed to digital innovation in healthcare, utilizing technologies such as cloud computing, big data, and artificial intelligence to enhance its service offerings[28]. - The company is actively exploring industrial financial services, leveraging its resources in the livelihood sector to serve industry chain groups[34]. - The company is focusing on expanding its market presence and business transformation in the smart IoT sector and new industry applications[57]. - The company aims to become a technology and service enterprise based on data chains, aligning with national strategies such as "Healthy China" and "Digital China"[111]. - The company is committed to continuous technological innovation to meet customer needs and improve service satisfaction[185]. Subsidiaries and Market Expansion - The company established 7 new subsidiaries in regions including Chongqing, Sichuan, Yunnan, and Tibet, enhancing market responsiveness and service levels[41]. - The company established four new subsidiaries in 2020, including 易联众健康科技有限公司 and 厦门万势顺易科技有限公司, while losing control over two subsidiaries[69][70]. - The company has developed a comprehensive service network integrating software systems, card services, and smart terminals, enhancing its overall service capabilities[37]. - The company has been recognized as a "2020 Provincial Leading Enterprise" and "Top 30 Internet Enterprises in Fujian Province"[41]. Research and Development - Research and development expenses increased by 16.37% year-on-year to 160,116,455.78 CNY, primarily due to higher personnel costs and depreciation[73]. - The company registered 265 new software copyrights, 3 invention patents, and 4 design patents during the reporting period[41]. - R&D investment amounted to CNY 201.87 million in 2020, representing 19.21% of total revenue, with capitalized R&D expenses of CNY 41.75 million, accounting for 20.68% of total R&D investment[75]. - The number of R&D personnel increased to 1,467 in 2020, making up 50.74% of the total workforce, compared to 49.11% in 2019[75]. Risk Management and Compliance - The company emphasizes the importance of reducing R&D costs and improving the competitiveness of its product systems and overall solutions[112]. - The company has taken measures to mitigate operational risks and enhance quality control in its business operations[97]. - The company has established a comprehensive independent labor, personnel, and compensation management system[132]. - The company has pledged to comply with legal and regulatory requirements to prevent any conflicts of interest[135]. Corporate Governance - All board members attended the meeting to review the annual report, ensuring comprehensive oversight of the report's content[3]. - The company has a robust internal management structure to enhance operational efficiency and reduce management risks[118]. - The company has implemented a comprehensive internal management and control system to enhance corporate governance and transparency for shareholders[184]. - The company has established an independent financial department and accounting system, ensuring compliance with regulations[133].